Clinical and demOgRaphic features of patients with uncontrolled Severe Asthma in Russia (CORSAR)

Trial Identifier:	D5180R00037
Sponsor:	AstraZeneca
Start Date:	June 2024
Primary Completion Date:	June 2027
Study Completion Date:	June 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Blagoveshchensk, Russia

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.